Global Veterinary Antibiotics Market Size to worth USD 6.50 Billion by 2033
According to a research report published by Spherical Insights & Consulting, The Global Veterinary Antibiotics Market Size is Expected to Grow from USD 4.97 Billion in 2023 to USD 6.50 Billion by 2033, at a CAGR of 2.72% during the forecast period 2023-2033.
Browse key industry insights spread across 210 pages with 110 Market data tables and figures & charts from the report on the Global Veterinary Antibiotics Market Size, Share, and COVID-19 Impact Analysis, By Animal Type (Pigs, Cattle, Sheep & Goats, and Poultry), By Drug Class (Tetracyclines and Penicillins), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033.
The veterinary antibiotics market encompasses the production, distribution, and application of antibiotics specifically designed for the treatment and prevention of bacterial infections in animals. This market caters to both companion animals and livestock, addressing the growing demand for animal health management and ensuring productivity and welfare in livestock farming. The increasing prevalence of bacterial infections among animals, coupled with the rising awareness of animal health, has significantly fueled the growth of the veterinary antibiotics sector. The market is primarily driven by the rising adoption of pets, the expansion of the livestock industry, and the growing focus on food safety and animal welfare. Technological advancements in antibiotic formulations and delivery systems further bolster market growth. Additionally, government initiatives and veterinary health programs aimed at improving animal healthcare infrastructure support market expansion. However, the veterinary antibiotics market faces challenges such as stringent regulatory frameworks governing antibiotic use in animals, the increasing incidence of antibiotic resistance, and the growing inclination toward alternative treatment methods such as probiotics and herbal medicines.
The poultry segment accounted for the largest share in 2023 and is expected to grow at a significant CAGR during the forecast period.
Based on the animal type, the veterinary antibiotics market is classified into pigs, cattle, sheep & goats, and poultry. Among these, the poultry segment accounted for the largest share in 2023 and is expected to grow at a significant CAGR during the forecast period. The dominance of the poultry segment can be attributed to the rising global demand for poultry meat and eggs, which necessitates the effective management of bacterial infections to ensure high production efficiency and quality. Additionally, the increasing prevalence of diseases such as colibacillosis and necrotic enteritis among poultry has further driven the demand for antibiotics in this segment.
The tetracyclines segment accounted for the largest share in 2023 and is expected to grow at a significant CAGR during the forecast period.
Based on the drug class, the veterinary antibiotics market is divided into tetracyclines and penicillins. Among these, the tetracyclines segment accounted for the largest share in 2023 and is expected to grow at a significant CAGR during the forecast period. The dominance of the tetracyclines segment is primarily driven by their broad-spectrum activity against a wide range of bacterial infections in both livestock and companion animals. Their affordability, ease of availability, and versatility in addressing respiratory, gastrointestinal, and systemic infections further contribute to their widespread adoption.
North America is estimated to hold the largest veterinary antibiotics market share over the forecast period.
North America is estimated to hold the largest veterinary antibiotics market share over the forecast period. The market growth is driven by the presence of established players and increasing demand for treatment among veterinary practices. According to the Centers for Disease Control and Prevention, Zoonotic diseases are prevalent globally, including in the United States. Scientists estimate that over 60% of known infectious diseases in humans can be transmitted from animals, and 75% of new or emerging infectious diseases in humans originate from animal sources. They pose an additional threat to public health as animals are the leading cause of zoonotic diseases. The high prevalence of zoonotic diseases is hence propelling the growth of the market.
Asia-Pacific is predicted to have the fastest CAGR growth in the veterinary antibiotics market over the forecast period. The growth of the market in the region can be attributed to the increasing adoption of pet animals, the growing health concerns in animals, the rising vigilance about animal health, the surging livestock population, and the prevalence of animal diseases.
Company Profiling
Major key players in the veterinary antibiotics market are Merck & Co., Inc., Ceva Santé Animale., Vetoquinol, Zoetis Services LLC, Boehringer Ingelheim International GmbH, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Virbac S.A., Calier, Bimeda, Inc, Prodivet pharmaceuticals SA/NV, and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In February 2024, the companies, Blacksmith Medicines and Zoetis announced today their collaboration to create novel antibiotics targeting metalloenzymes for animal health to address antibiotic resistance. Blacksmith's platform uses metal-binding pharmacophores and computational tools to drug metalloenzymes, while Zoetis adds its veterinary expertise and pathogen library to reduce reliance on antibiotics critical for human health.
Market Segment
This study forecasts global, regional, and country revenue from 2023 to 2033. Spherical Insights has segmented the veterinary antibiotics market based on the below-mentioned segments:
Global Veterinary Antibiotics Market, By Animal Type
- Pigs
- Cattle
- Sheep & Goats
- Poultry
Global Veterinary Antibiotics Market, By Drug Class
- Tetracyclines
- Penicillins
Global Veterinary Antibiotics Market, By Regional Analysis
- North America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa